%D8%A7%D9%84%D8%AA%D9%87%D8%A7%D8%A8_%D8%A7%D9%84%D9%83%D8%A8%D8%AF_%D8%A7%D9%84%D9%81%D9%8A%D8%B1%D9%88%D8%B3%D9%8A_%D8%AFHepatitis_DCategory:Hepatitis_DHepatitis_D%DE%80%DE%AC%DE%95%DE%A6%DE%93%DE%A6%DE%87%DE%A8%DE%93%DE%A8%DE%90%DE%B0_%DE%91%DE%A9Hepatitis_DHepatitis_D%D9%87%D9%BE%D8%A7%D8%AA%DB%8C%D8%AA_%D8%AF%DB%8CH%C3%A9patite_DHepatitis_D_virus%E0%A4%B9%E0%A5%88%E0%A4%AA%E0%A5%87%E0%A4%9F%E0%A4%BE%E0%A4%87%E0%A4%9F%E0%A4%BF%E0%A4%B8_%E0%A4%A1%E0%A5%80%D5%80%D5%A5%D5%BA%D5%A1%D5%BF%D5%AB%D5%BF_DEpatite_DD%E5%9E%8B%E8%82%9D%E7%82%8E%D0%92%D0%B8%D1%80%D1%83%D1%81%D1%82%D1%8B_%D0%B3%D0%B5%D0%BF%D0%B0%D1%82%D0%B8%D1%82_%D0%94D%ED%98%95_%EA%B0%84%EC%97%BC%E0%B4%B9%E0%B5%86%E0%B4%AA%E0%B5%8D%E0%B4%AA%E0%B4%B1%E0%B5%8D%E0%B4%B1%E0%B5%88%E0%B4%B1%E0%B5%8D%E0%B4%B1%E0%B4%BF%E0%B4%B8%E0%B5%8D-%E0%B4%A1%E0%B4%BFHepatitt_DHepatite_DHepatit%C4%83_D%D0%93%D0%B5%D0%BF%D0%B0%D1%82%D0%B8%D1%82_DHepatitis_DHepatitis_D%D0%93%D0%B5%D0%BF%D0%B0%D1%82%D0%B8%D1%82_D%DB%81%DB%8C%D9%BE%D8%A7%D9%B9%D8%A7%D8%A6%D9%B9%D8%B3_%DA%88%DB%8CQ327281%E4%B8%81%E5%9E%8B%E8%82%9D%E7%82%8E
about
Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda InterferonChronic Hepatitis B Virus Infection in ZambiaLonafarnib for Chronic Hepatitis DProof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV)Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2aA Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)Mother-to-child Hepatitis D TransmissionLonafarnib With Ritonavir in HDV (LOWR-2)Lonafarnib With and Without Ritonavir in HDV (LOWR-1)REP 2139-Ca / Pegasys™ Combination Therapy in Hepatitis B / Hepatitis D Co-infectionHIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta HepatitisPhase 3 Study of Bulevirtide in Patients With CHDPhase 2b Study of Bulevirtide (With Peginterferon Alfa-2a) in Patients With CHDA Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis DEpidemiology of Hepatitis B, C and Delta in Reunion IslandStudy of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)Titrating-Dose of Lonafarnib in Combination With RitonavirTreatment of Chronic Delta Hepatitis With Lonafarnib and RitonavirThe Hepatitis Delta International NetworkLiver Fibrosis in Zambian HIV-HBV Co-infected PatientsAn Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a)Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and DeltaPegylated Interferon to Treat Chronic Hepatitis DEzetimibe for Patients With Chronic Hepatitis DHepatitis Delta Infections in HemophiliacsLamivudine for Chronic Hepatitis BA Study of Lonafarnib With or Without Ritonavir in Patients With HDVA Long Term Follow-up Study of Patients From the REP 301 ProtocolHepatitis D Virus Infection Among Hepatitis B Virus Surface Antigen Positive IndividualsPegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis DA Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus InfectionMyrcludex B Plus Pegylated Interferon-alpha-2a in Patients With HBeAg Negative HBV/HDV Co-infectionA Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)Observatory of Efficacy and Safety of Bulevirtide in Patients With Chronic HBV/HDV Co-infectionStudy the Content of the HBV DNA in Liver Biopsy in the Patients Chronic Hepatitis Delta
P1050
Hepatitis delta: epidemiology, diagnosis and management 36 years after discoveryAn overview of triple infection with hepatitis B, C and D viruses.Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis.Hepatitis delta: virological and clinical aspects.Bona fide receptor for hepatitis B and D viral infections: Mechanism, research models and molecular drug targetsThe Epidemiology of Hepatitis D Virus in North Africa: A Systematic Review and Meta-AnalysisHepatitis D prevalence: problems with extrapolation to global population estimatesHepatitis D: not a rare disease anymore: global update for 2017-2018Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis DTreatment of Chronic Delta Hepatitis With Lonafarnib and RitonavirPegylated Interferon to Treat Chronic Hepatitis DEzetimibe for Patients With Chronic Hepatitis DEvaluation of Patients With Liver DiseasePegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis DEpidemiology of the Hepatitis D virus
P921
Q61907689-05B1527F-9268-492F-A3FF-E36CABC24AAAQ61909401-17E36BED-277E-4480-B498-5E4A0D45C6DFQ63319381-44BB7F69-5ED6-4897-B2D6-7958CF1FBDE7Q63338143-DE69920C-0C4D-430D-9D29-B79D4BAED107Q63811635-08D9A10C-BC74-4602-8D15-A3DEA157BB2BQ63836129-7C4C2FD5-CCA8-4A34-9697-BBDFAB8AEF29Q64045642-DE06E0D1-35FB-4DA5-9EBD-F6DB9A3A9E64Q64348692-FC287E71-D200-4B2C-B931-26308EEFF862Q64394133-6293CB30-8B98-4BB9-ADE5-67202DF12D42Q64394136-F18CEFED-2B27-4A5F-BEED-F3CC36BA57ABQ64607160-C653305A-202C-44E2-B44C-C0A6CBA407F6Q64673547-584B394D-2A9F-4DCA-AE62-3AD908EE5BB1Q64793505-43A377DF-CB37-43EC-88E4-A7873B2E9745Q64793547-81145FE4-531D-4334-82BD-4CB605FBFBEFQ64796582-25465B50-6643-4C60-8E9F-210D9AD25461Q64807355-7631DC39-24D7-4ED6-A8D8-6DB7B8F55223Q65316719-72378319-5434-445D-ACAA-88EF96526999Q65336314-10C00B7A-649A-4B11-A746-DC446200CABEQ65337961-5439C7CD-F80C-443F-B22E-AF9C5D44A2D8Q65347079-FC039F89-D564-4ED8-8CE7-4CD9CC0E19FFQ65348775-3D6A8A85-306F-43D4-9307-75A62D35073CQ65366224-CC5B61F8-67AF-4EF0-9C97-3C0B0DCC6192Q66033166-3BF6279D-812C-4DE2-92DD-24E233EA5BB1Q66039752-BF11EEA5-933B-4CD1-BE92-AD0B2795B246Q66046232-4569D12D-B9F2-4272-A621-0142FDAF73EAQ66060385-14EAFBB9-1581-4073-8B36-FDE24C1A2DD2Q66061256-3A80CDF8-46C6-48E6-A31D-47E8219C780EQ66078637-4D03AEBF-48F9-4F33-8A19-0A1C039F055BQ66083149-61FA2FC1-DD7C-401E-87BC-C4BBED82C268Q66388748-D4F2B7AA-3894-4636-B3C4-57F7508F9127Q66390231-5DCE3773-B610-4A8D-90C8-71D75D2919E5Q66404592-1B11B44D-B00A-4A69-BB6E-A5C723B93F0CQ66409624-65952375-D10D-4ACC-9AC4-082E0A66502AQ66546528-C8C2001E-0F14-41FE-9136-DC5C0887CB95Q66546758-F14197A3-FE12-4280-95F5-B43016989715Q76978926-7CBDAE29-F8E2-400B-90C6-972C919D43D5Q76980008-94269CAE-D89D-4BED-9E4C-F6A22AD668D6
P1050
Q26849602-F5BAAEEA-2FA6-44BC-80D3-F7BF4C015848Q30485092-33429498-D1EB-4994-A361-2C9758D5FD13Q40040535-FB8562A8-D9D9-4809-BB64-29EE11A20B15Q40042818-BC30D987-E9A0-46D2-9024-F42CEF0C53BDQ57114097-73E9E1E8-6D97-46FD-B46B-6125B71BC2DEQ57821333-BFDF3334-A628-4184-8FA5-A33F73A35CF4Q62488019-11D609B1-DB2F-46B4-9F3A-CDAF6A9DA84BQ64039574-123916C5-5652-40A5-ACA8-3027C9DDD36BQ64045642-D2E3A301-F496-428B-9342-33B6042A6DA6Q64796582-7BD074E4-ABD2-4754-AE19-4A2CAE8B8CF1Q65337961-53A6BF33-9120-47EE-8BD8-B44A34150F9FQ66039752-FCD4FD7A-88DF-400C-9AC6-D412D91846BDQ66046232-A1293988-0057-4B6F-AD4D-246CDBE285EEQ66060819-87B001C1-9D94-4D0B-859E-AB2430F2C20AQ66390231-8FD913A2-039E-433C-B9B1-C7A2E50E2C1AQ89093122-8bdc9360-429b-e484-13e4-76f01a1ef10a
P921
description
Human disease
@en
Human disease
@id
Krankheit
@de
epatite virale causata dal virus HDV, chiamato anche "virus delta"
@it
zánětlivé onemocnění jater
@cs
один з видів вірусних гепатитів людей
@uk
مرض يصيب الإنسان
@ar
name
D型肝炎
@ja
D型肝炎
@zh-hant
D型肝炎
@zh-sg
D型肝炎
@zh-tw
D형 간염
@ko
Hepatitis D virus
@he
Hepatitis D
@de
Hepatitis D
@nl
Hepatitis D
@sl
Hepatitis D
@tl
type
label
D型肝炎
@ja
D型肝炎
@zh-hant
D型肝炎
@zh-sg
D型肝炎
@zh-tw
D형 간염
@ko
Hepatitis D virus
@he
Hepatitis D
@de
Hepatitis D
@nl
Hepatitis D
@sl
Hepatitis D
@tl
altLabel
D型肝炎
@zh
Epatite virale D
@it
HDV
@en
HDV
@he
Hepatitis D virus
@en
delta hepatitis
@en
delta hepatitis
@id
hepatitis D
@cs
hepatitis delta
@en
hepatitis type D
@en
prefLabel
D型肝炎
@ja
D型肝炎
@zh-hant
D型肝炎
@zh-sg
D型肝炎
@zh-tw
D형 간염
@ko
Hepatitis D virus
@he
Hepatitis D
@de
Hepatitis D
@nl
Hepatitis D
@sl
Hepatitis D
@tl
P279
P2888
P672
P486
P6366
P646
P1417
science/hepatitis-D-virus
P1550
P1692
P1995
P279
P2892
P373
Hepatitis D
P3827
hepatitis-delta-virus
P4229
P486
P493
P5270
MONDO:0005789